Uncontrolled Gout

6 registered clinical trials studyying Uncontrolled Gout — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Peglo NCT07388498	Amgen	Phase 3
Recruiting	Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients NCT07116746	Arthrosi Therapeutics	Phase 2
Completed	Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegl NCT04772313	Amgen	Phase 4
Completed	A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients Wi NCT04762498	Amgen	Phase 4
Completed	Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in NCT04511702	Amgen	Phase 4
Completed	Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant NCT04087720	Amgen	Phase 4